日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7

抑制 METTL3 可通过增加 NEK7 泛素化来减轻 NLRP3 炎症小体的活化

Xinyi Zhou, Xiaoyu Yang, Shenzhen Huang, Guifeng Lin, Kexin Lei, Qian Wang, Weimin Lin, Hanwen Li, Xingying Qi, Dutmanee Seriwatanachai, Shengyong Yang, Bin Shao, Quan Yuan

Targeting Noncanonical Pyroptosis With a Small Molecular Inhibitor Alleviates Inflammation in the LPS-Induced Keratitis Mouse Model

利用小分子抑制剂靶向非经典细胞焦亡可减轻LPS诱导的角膜炎小鼠模型中的炎症。

Yun Zhang ,Nenghua Zhou ,Yan Jiao ,Guifeng Lin ,Xun Li ,Sheng Gao ,Pei Zhou ,Jingming Liu ,Jinshan Nan ,Meixia Zhang ,Shengyong Yang

Cryo-EM structures of human GPR34 enable the identification of selective antagonists

人类 GPR34 的低温电子显微镜结构能够识别选择性拮抗剂

Anjie Xia #, Xihao Yong #, Changbin Zhang #, Guifeng Lin #, Guowen Jia #, Chang Zhao #, Xin Wang #, Yize Hao #, Yifei Wang, Pei Zhou, Xin Yang, Yue Deng, Chao Wu, Yujiao Chen, Jiawei Zhu, Xiaodi Tang, Jingming Liu, Shiyu Zhang, Jiahao Zhang, Zheng Xu, Qian Hu, Jinlong Zhao, Yuting Yue, Wei Yan, Zhao

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing

HDAC 抑制剂改善 CRISPR-Cas9 介导的原始编辑和碱基编辑

Nan Liu, Lifang Zhou, Guifeng Lin, Yun Hu, Yaoge Jiao, Yanhong Wang, Jingming Liu, Shengyong Yang, Shaohua Yao

Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis

发现一种新型强效抑制剂,其对 NLRP3 和 AIM2 炎症小体依赖性细胞焦亡具有不同的物种特异性作用

Yan Jiao, Jinshan Nan, Bo Mu, Yun Zhang, Nenghua Zhou, Shunhua Yang, Shanshan Zhang, Wanting Lin, Falu Wang, Anjie Xia, Zhixing Cao, Pei Chen, Zhiling Pan, Guifeng Lin, Shulei Pan, Huachao Bin, Linli Li, Shengyong Yang

Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays

通过基于结构的虚拟筛选、结构优化和生物测定发现人类 TyrRS 抑制剂

Shenzhen Huang, Xiang Wang, Guifeng Lin, Jie Cheng, Xiuli Chen, Weining Sun, Rong Xiang, Yamei Yu, Linli Li, Shengyong Yang